Th2 cells as targets for therapeutic intervention in allergic bronchial asthma (Q37355888)

19 August 2017

1 reference

title

Th2 cells as targets for therapeutic intervention in allergic bronchial asthma (English)

1 reference

19 August 2017

0 references

Michael Wegmann

1

1 reference

19 August 2017

publication date

1 January 2009

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

19 August 2017

published in

1 reference

19 August 2017

volume

9

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

85-100

1 reference

Asthma. From bronchoconstriction to airways inflammation and remodeling

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin-13: central mediator of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Molecular mechanisms of immunoglobulin E regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

New insights into the role of cytokines in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Eosinophil trafficking in allergy and asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Eosinophilia in transgenic mice expressing interleukin 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Mast cells are essential intermediaries in regulatory T-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Requirement for IL-13 independently of IL-4 in experimental asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin-13 in asthma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Targeting TNF-alpha: a novel therapeutic approach for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Role of tumor necrosis factor in toluene diisocyanate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Evidence of a role of tumor necrosis factor alpha in refractory asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Development in motion: helper T cells at work

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

T-helper cell type-2 regulation in allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Distinct dendritic cell subsets differentially regulate the class of immune response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Transcriptional mechanisms underlying lymphocyte tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

NFAT proteins: key regulators of T-cell development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Partners in transcription: NFAT and AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Characterization of P5, a novel NFAT/AP-1 site in the human IL-4 promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

An IL-13 promoter polymorphism associated with increased risk of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

NFAT signaling: choreographing the social lives of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

A new cell-permeable peptide allows successful allogeneic islet transplantation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Th2 cell-specific cytokine expression and allergen-induced airway inflammation depend on JunB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

T helper type 2 cytokine receptors and associated transcription factors GATA-3, c-MAF, and signal transducer and activator of transcription factor-6 in induced sputum of atopic asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

NF-AT-Driven interleukin-4 transcription potentiated by NIP45

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

A stage-specific functional role of the leucine zipper transcription factor c-Maf in lung Th2 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

TH2 cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Essential role of Stat6 in IL-4 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Signaling pathways regulating interleukin-13-stimulated chemokine release from airway smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Regulation of Th2 differentiation and Il4 locus accessibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Transgenic mice which overproduce Th2 cytokines develop spontaneous atopic dermatitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Lentiviral-mediated GATA-3 RNAi decreases allergic airway inflammation and hyperresponsiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Essential and instructive roles of GATA factors in eosinophil development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Transcription factor GATA-3 is required for development of the T-cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

21 January 2018

Chemokines and disease

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Eotaxin Receptor (CCR3) Antagonism in Asthma and Allergic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Functional expression and characterization of macaque C-C chemokine receptor 3 (CCR3) and generation of potent antagonistic anti-macaque CCR3 monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Discovery of potent CCR4 antagonists: Synthesis and structure-activity relationship study of 2,4-diaminoquinazolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin-15 protects from lethal apoptosis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin 25 promotes the initiation of proallergic type 2 responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Essential autocrine regulation by IL-21 in the generation of inflammatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Role of interleukin-21 in inflammation and allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

The IL-21 receptor augments Th2 effector function and alternative macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

A role for TSLP in the development of inflammation in an asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Allergen-specific production of interferon-gamma by peripheral blood mononuclear cells and CD8 T cells in allergic disease and following immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Cloning of a new cytokine that induces IFN-gamma production by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

IL-2 and IL-18 attenuation of airway hyperresponsiveness requires STAT4, IFN-gamma, and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

The germless theory of allergic disease: revisiting the hygiene hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Toll-like receptors: function and roles in lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Apoptosis in tissue inflammation and allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Transforming growth factor-beta regulates house dust mite-induced allergic airway inflammation but not airway remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Reduced expression of transforming growth factor beta 1 exacerbates pathology in an experimental asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Transforming growth factor-beta induces development of the T(H)17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Regulatory T cells in allergy and asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Immunological mechanisms of allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

Images in allergy and immunology: neutrophils in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

21 January 2018

Omalizumab for asthma

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.85

21 January 2018

Identifiers

DOI

10.1586/14737159.9.1.85

1 reference

19 August 2017

1 reference